The role involves leading a team to investigate the mechanisms of efficacy and resistance to radioligand therapy within the Oncology Translational Research group
Job Summary
The role involves leading a team to investigate the mechanisms of efficacy and resistance to radioligand therapy within the Oncology Translational Research group.
Candidates will design and execute preclinical translational studies and clinical biomarker plans while collaborating across drug discovery and early clinical development groups.
The position offers a comprehensive benefits package including health, life, disability benefits, a 401(k) match, and eligibility for annual equity awards.
Matching Summary
The role involves leading a team to investigate the mechanisms of efficacy and resistance to radioligand therapy within the Oncology Translational Research group.
Salary
Base: $108,500 - $201,500 per year; Bonus/Equity: Performance-based cash incentive and potential annual equity awards; Benefits: Health, life, disability, 401(k) with match, and generous time off
Skills & Requirements
Must-have
Ph.D. in molecular or cancer biology
Experience with cell death mechanisms
Knowledge of DNA damage response and repair
Proficiency in data mining and computational skills